Small Scale Projects - Advancing Innovative Smoking Cessation through Dissemination, Implementation & Training Grants

Overview

Small Scale Projects: Advancing Innovative Smoking Cessation through Dissemination, Implementation & Training Grants

Call for Proposals

Consistent with its charitable mission, Global Action to End Smoking (GA) seeks proposals for innovative grant programs that disseminate science-based information about smoking cessation tools that are available to people who smoke, their healthcare providers, health journalists including the wider media community, and the general public. This Request for Proposal (RFP) will fund diverse strategies within GA’s strategic plan relating to its Dissemination, Implementation, and Training (DIT) workstream, tailored to the needs of respective countries or populations, that:

* increase awareness of locally available cessation options and their importance,
* correct widespread misperceptions about the relative risk of nicotine compared to combusted tobacco, and
* disseminate accurate and consistent messaging about the potential role of reduced-risk nicotine products for smokers who cannot or will not quit using traditional interventions.

Additionally, GA encourages strong implementation research that examines the important and dynamic contextual factors that may influence the effectiveness of interventions in specific LMICs, or for marginalized populations in HICs. Strategic goals of this RFP are to identify the most promising programs for DIT, build capacity for DIT programs around the world, and generate widely accessible case studies that share local and contextualized findings about how to design and implement effective interventions, including description of the country-specific barriers and facilitators to successful implementation.

Objective

GA invites proposals for Advancing Innovative Smoking Cessation through Dissemination, Implementation & Training Grants. GA’s strategic objective is to accelerate comprehensive, science-based global efforts to end the smoking epidemic, with a focus on LMICs and marginalized populations in HICs. GA funds innovative research and programs that relate to three “smoke-free purposes,” described in GA’s Certificate of Incorporation, Article Third. This RFP will provide grant funding opportunities for small-scale investigator-initiated applications that address GA’s broad areas of interest in Dissemination, Education, and Training.

For small-scale DIT projects, applications should clearly explain why the program has high potential to increase public knowledge or awareness, correct nicotine misperceptions, and engage diverse audiences. Proposals for small-scale programs must be grounded in adequate prior evidence and demonstrate an understanding of relevant literature. However, GA will consider developmental or exploratory programs within this small-scale RFP that are limited in focus, or may provide foundational insights to advance DIT.

Funding

Maximum of USD 500,000 total, amount consistent with proposal and work plan.

Eligibility

_We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's [website]()%20Advancing%20Innovative%20Smoking%20Cessation%20through%20Dissemination,%20Implementation%20&%20Training%20Grants.pdf).
_

Application Details

Dissemination, Implementation & Training
Request for Proposals
TOPIC
Cessation Education
Advancing Innovative Smoking Cessation through
Dissemination, Implementation & Training Grants
Open Funding (Quarterly) Announcement for Small-
Scale Investigator-Initiated Applications
Issue date Friday, November 22, 2024
Closing dates Friday May 23, 2025
Closing time 12:00 PM – UK Time
Submit proposals to See submission instructions in RFP
Financing instrument Grant
Maximum of USD 500,000 total,
Financing amount
amount consistent with proposal and work plan
Maximum of 12 months,
Financing duration
consistent with proposal and work plan
Contact information support@actiontoendsmoking.org
_______________________________________________________________________________________________________
Cessation Education: Advancing Innovative Smoking Cessation through Dissemination, Implementation, and Training Grants
Quarterly Funding Announcement Small-Scale Page 1 of 12

Background
Cigarette smoking is the leading cause of preventable death and disease in the world, resulting in
8 million deaths each year from tobacco use.[1] Over one billion people still smoke cigarettes, and
80 percent live in low-and middle-income countries (LMICs).[1-2] While smoking rates have
declined overall in high-income countries (HICs), rates in LMICs are declining slower or even
rising in some regions.[2] Within HICs, relative disparities persist among marginalized populations
who smoke at higher rates than the general population, including people of low socio-economic
status, people with mental health conditions or substance use disorders, sexual and gender
minorities, and Indigenous peoples.[3] More than 60% of smokers worldwide express a desire to
quit smoking, yet over 70% lack access to cessation services.[4] Most smokers who quit do so
without any assistance (“cold turkey”) and struggle through multiple quit attempts.[5-6]
Nicotine is the addictive chemical within cigarettes, and it can make quitting difficult, but it is not
one of the chemicals in combusted tobacco smoke that cause tobacco-related cancer, lung disease,
or cardiovascular disease.[7] When nicotine is separated from combusted tobacco, it is approved as
safe and effective for use as nicotine replacement therapy (e.g., gums, patches, lozenges), an
evidence-based intervention to help smokers quit. Nicotine is also present in non-medicinal
reduced risk products (RRPs) that can be used for cessation such as e-cigarettes, snus, nicotine
pouches, and heated tobacco products. High-quality evidence demonstrates that e-cigarettes
significantly decrease exposure to harmful and potentially harmful chemicals that cause tobacco-
related disease, and are more effective than NRT to help smokers quit.[8-9]
Despite robust scientific evidence, and regulatory frameworks such as United States Food & Drug
Administration’s “continuum of risk” that center on nicotine and the relative risks of different
tobacco products, there are longstanding and widespread misperceptions about the health effects
of nicotine compared to combusted tobacco.[7] The general public, smokers, and even physicians
around the world [10-12] still incorrectly equate the harms of nicotine with the harms of cigarette
smoking. Due to conflicting or false information, many people believe that NRT and RRPs are
equally harmful, if not more harmful, than cigarettes. These misperceptions blunt the potential
effect of cessation tools containing nicotine, preventing smokers from switching to RRPs and away
from cigarettes - the highest risk tobacco product.
Nicotine is not completely without risk, and its use should not be encouraged among non-users.[13]
However, there is an urgent need to correct nicotine misperceptions for people who smoke.
Cessation rates remain low across LMICs and HICs, even where evidence-based interventions
such as NRT, Quitlines, or pharmacological interventions are available. Across countries, uptake
is low and effects are modest.[5-6] Longstanding nicotine misperceptions may partially explain low
uptake of NRT and may now extend to RRPs that can serve as effective and accessible alternatives.
New interventions that explain the relative risks of different tobacco products, and identify all
locally relevant options for cessation, are critical to disseminate accurate information smokers can
use to make informed and individualized decisions about how to quit.
_______________________________________________________________________________________________________
Cessation Education: Advancing Innovative Smoking Cessation through Dissemination, Implementation, and Training Grants
Quarterly Funding Announcement Small-Scale Page 2 of 12

Call for Proposals
Consistent with its charitable mission, Global Action to End Smoking (GA) seeks proposals for
innovative grant programs that disseminate science-based information about smoking cessation
tools that are available to people who smoke, their healthcare providers, health journalists
including the wider media community, and the general public. This Request for Proposal (RFP)
will fund diverse strategies within GA’s strategic plan relating to its Dissemination,
Implementation, and Training (DIT) workstream, tailored to the needs of respective countries or
populations, that:
(1) increase awareness of locally available cessation options and their importance,
(2) correct widespread misperceptions about the relative risk of nicotine compared to
combusted tobacco, and
(3) disseminate accurate and consistent messaging about the potential role of reduced-risk
nicotine products for smokers who cannot or will not quit using traditional interventions.
Additionally, GA encourages strong implementation research that examines the important and
dynamic contextual factors that may influence the effectiveness of interventions in specific
LMICs, or for marginalized populations in HICs. Strategic goals of this RFP are to identify the
most promising programs for DIT, build capacity for DIT programs around the world, and generate
widely accessible case studies that share local and contextualized findings about how to design
and implement effective interventions, including description of the country-specific barriers and
facilitators to successful implementation.
Objective
GA invites proposals for Advancing Innovative Smoking Cessation through Dissemination,
Implementation & Training Grants. GA’s strategic objective is to accelerate comprehensive,
science-based global efforts to end the smoking epidemic, with a focus on LMICs and
marginalized populations in HICs. GA funds innovative research and programs that relate to three
“smoke-free purposes,” described in GA’s Certificate of Incorporation, Article Third. This RFP
will provide grant funding opportunities for small-scale investigator-initiated applications that
address GA’s broad areas of interest in Dissemination, Education, and Training and will be open
for up to one year with quarterly submission deadlines posted on the GA website. See a companion
RFP for small-scale Health & Science Research (H&SR RFP).
GA encourages applicants to review GA’s website to understand the goals of DIT, and propose
new and creative strategies that are feasible, acceptable, and tailored to the population of interest.
For small-scale DIT projects, applications should clearly explain why the program has high
potential to increase public knowledge or awareness, correct nicotine misperceptions, and engage
diverse audiences. Proposals for small-scale programs must be grounded in adequate prior
evidence and demonstrate an understanding of relevant literature. However, GA will consider
_______________________________________________________________________________________________________
Cessation Education: Advancing Innovative Smoking Cessation through Dissemination, Implementation, and Training Grants
Quarterly Funding Announcement Small-Scale Page 3 of 12

developmental or exploratory programs within this small-scale RFP that are limited in focus, or
may provide foundational insights to advance DIT.
Proposals should be designed as programs. Scoring criteria used by GA for DIT are listed on our
website and within this RFP (see Table 1). Program proposals should include: (1) a clear description
of the core elements of the program, (2) a rationale explaining how and why the program elements
will result in the expected change, (3) published research to support the programmatic approach,
(4) a simple program evaluation plan with measurable indicators and (5) a brief description of the
country context or population including the current level of awareness and availability of cessation
options including reduced risk nicotine products, expected barriers to success, and pro-active
strategies to overcome barriers. For applicants implementing programs in settings where
misinformation is widespread (as opposed to settings where general information about cessation
is low), describing the country context of misinformation, and how it will be addressed, is essential
to the application. For all countries and settings, regardless of the respective level of
misinformation/information, GA requires the development of practical and brief case studies as a
grant deliverable.
GA encourages proposals from diverse disciplines to support interdisciplinary approaches to
developing new DIT interventions. Applicants are not required to be subject matter experts in
health communications or educational interventions, but they should reference published research
from public health or health communications on similar projects to justify the approach. Applicants
are strongly encouraged to utilize the Dissemination, Implementation, and Training Reference
Index to identify examples of relevant published literature that can be cited in applications or be
used to help inform design and implementation. The Repository also contains technical assistance
resources such as health communications guides, implementation frameworks, and public health
program evaluation frameworks to assist in the development of proposals.
Small-Scale DIT Programs: Example Topics
This RFP is specifically designed for small-scale or “developmental” programs that are smaller in
scope than large-scale or confirmatory programs which in contrast would be more appropriate for
the larger funding announcement (concurrently posted here). The overarching goal is to provide
support for investigator-initiated projects in the early/conceptual phases of research or other small-
scale projects with high research efficiency. Applicants are expected to describe the anticipated
and immediate implications of the program results on public health practice or in future programs.
Applicants who are unsure about what mechanism to use are encouraged to reach out to GA via
the support e-mail function.
Types of projects that may be eligible for this funding announcement may include:
1. Single, small projects that can be executed in a short time period with limited resources.
2. Early or conceptual research to gain sufficient evidence to answer key exploratory,
_______________________________________________________________________________________________________
Cessation Education: Advancing Innovative Smoking Cessation through Dissemination, Implementation, and Training Grants
Quarterly Funding Announcement Small-Scale Page 4 of 12

developmental, or foundational questions (e.g., qualitative or quantitative research
designed for discovery; generation of new hypotheses; secondary data analysis of
existing data sets).
3. Implementation research that aims to translate previous scientific findings into new
contexts (e.g., tests of external validity for behavioral interventions; implementation
models to explain factors that influence implementation or adoption outcomes).
4. Pilot, feasibility, or acceptability testing of new locally-effective interventions, public
health programs, or new approaches to measurement, modeling, or methodology.
Unlike large-scale, population-level projects funded by GA, small-scale projects might not yield
generalizable results, although the justification for the study and implications of the results should
be clear. All applications must have a rigorous project plan and use the same submission forms as
large-scale projects. Applicants should present proposals that address a significant problem or
research question, using a well-grounded approach appropriate for smaller-scale research.
Applicants are expected to complete the study within the stipulated period (not to exceed 12
months).
Proposals should align with GA’s broad areas of interest related to DIT. Project approaches might
include, but are not limited to, public health communications, educational interventions, public
information campaigns, and community engagements that are highly-tailored to the priority
population and setting such as:
• Health communications and awareness campaigns designed to 1) increase fact-
based information about available smoking cessation options and 2) facilitate
informed decision-making about how to quit smoking. Communications may be
targeted to people who smoke or those who assist them in their cessation journeys
(e.g., small-scale campaigns about locally relevant resources including NRT, Quitlines,
or reduced-risk nicotine products; development of digital, website, print, or audio
materials; community engagement events; stakeholder communications; identifying and
using key opinion leaders; embedding DIT in existing community health
education/disease prevention programs)
• Dissemination activities designed to correct existing nicotine misperceptions AND
accurately communicate the relative risks of tobacco products to stakeholders or
people who smoke (e.g., communicating FDA’s Continuum of Risk by translating
scientific evidence to lay audiences; network or coalition building to disseminate clear
and consistent messaging; supporting accurate and complete reporting by media;
implementation science models that describe approaches to correcting nicotine
misinformation in challenging contexts or models that identify the underlying factors
that contribute to misinformation and how to address them).
• Training for frontline health care professionals, especially those that serve
populations with higher smoking rates (e.g., education programs for providers who
directly interact with smokers, including community health workers; systems-wide
communications within public health practice, community settings, clinics, or other
_______________________________________________________________________________________________________
Cessation Education: Advancing Innovative Smoking Cessation through Dissemination, Implementation, and Training Grants
Quarterly Funding Announcement Small-Scale Page 5 of 12

health care systems; continuing education for physicians; development of health care
provider networks and events)
• Education activities that address sociodemographic disparities in smoking cessation
outcomes in LMICs or HICs (e.g., characterizing needs of priority populations seeking
access to smoking cessation options to inform development of tailored programs;
messages tailored to underserved populations with historically poor cessation outcomes
or higher failed quit attempts; community-based participatory methods that directly
engage people who smoke in the development of the program)
• Education or training activities designed to increase research capacity in LMICs or
among under-represented groups (e.g., conferences, webinars, or other in-person or
virtual meetings; mentoring or research collaborations; dissemination of research and
research methods to prioritized countries, priority populations, or low-resourced settings;
development of training materials or published materials to increase reach of research).
The topics listed above are only a few examples that are aligned with GA’s charitable mission and
are not meant to be exhaustive or exclusive. Applicants may choose to propose creative programs
outside of this list, or programs that address overlaps between the topics listed above. GA will
consider appropriate methodologies best suited for the applicant’s chosen area(s) of focus. GA
welcomes submissions from new investigators with diverse backgrounds outside of tobacco
control or smoking cessation, investigators from underrepresented groups in smoking cessation
research, and investigators from low-resource environments. Applicants are expected to complete
the project within the stipulated period and have an appropriate plan for dissemination and
communication of results.
The findings (including null results) of funded research should be appropriately disseminated to
increase the potential for positive, real-world impact on public health and individual smokers.
Applicants should establish a comprehensive plan to disseminate new knowledge through effective
channels relevant to the scope of research, country context, and priority audience. The final
product(s) for dissemination should demonstrate how findings will be used and how they will be
made accessible within the specific country or population. Final products should include
suggestions for further action as well as recommendations for future research areas.
Dissemination plans may include conference presentations, technical reports, case studies, or other
“grey literature” that is widely accessible to the country or population of interest. Research findings
may also be submitted to a peer-reviewed academic journal for publication as a primary
dissemination strategy, if appropriate to the scope of the research (for small-scale programs, other
dissemination strategies may be sufficient). Applicants must disclose GA as the source of funding
in journal articles. To ensure findings can be accessible to researchers in diverse countries as well
as the general public, GA encourages publication in open-access journals when possible.
Finally, GA requires the development of country- or population-specific case studies that
describe the implementation of new DIT initiatives and can be shared with future applicants to
_______________________________________________________________________________________________________
Cessation Education: Advancing Innovative Smoking Cessation through Dissemination, Implementation, and Training Grants
Quarterly Funding Announcement Small-Scale Page 6 of 12

support GA’s DIT workstream. Case studies should document implementation processes, describe
the key factors that enabled progress or presented barriers, and demonstrate measured outcomes.
Case studies must be listed as a grant deliverable. GA technical staff will provide more
information about case study requirements (including example templates) after grant awards.
Eligibility
Eligible institutions include academic, think-tank, and health-related research and science centers,
and other collaborating centers and institutions with experience in related subject areas such as public
health, behavioral health, psychology, epidemiology, economics, disease prevention, and health
communications. Previous experience in research related to smoking cessation, tobacco control,
marginalized populations, or harm reduction-informed approaches to public health is desirable but
not required. Proposals should be submitted by entities registered in their country of origin with an
ability to accept grants from not-for-profit foundations incorporated in the United States.
Geographic/Population Focus
GA’s goal is to fund investigator-initiated projects that generate new knowledge specific to
populations disproportionately burdened by the smoking epidemic, and those that experience
persistent tobacco-related health disparities. A geographic priority is countries with high smoking
rates and disease burden from traditional tobacco use, with a focus on LMICs and the populations
most at risk for premature morbidity and mortality. GA also prioritizes programs specific to
marginalized populations within HICs with historically high smoking rates and those with poor
cessation outcomes including, but not limited to, people of low socioeconomic status, sexual and
gender minorities, people with mental health conditions or substance use disorders, and Indigenous
peoples.
Applicants should provide relevant information about the country or population of interest, a
rationale for selecting the priority study population, and available resources to reach the population
and implement programs as planned (e.g., existing professional networks, previous stakeholder
engagement activities). If programs are specific to reduced risk nicotine products, programs should
be conducted where those products are legally available. However, GA may also review
applications for programs in localities where reduced risk nicotine products are not available
depending on the aims and scope of the proposed program.
Estimated Budget, Duration, and Timelines
Budget
The application budget needs to be consistent with the small-scale proposal and respective work plan.
Awards for this announcement may not exceed USD 500,000 per project.
_______________________________________________________________________________________________________
Cessation Education: Advancing Innovative Smoking Cessation through Dissemination, Implementation, and Training Grants
Quarterly Funding Announcement Small-Scale Page 7 of 12

Duration
The scope of the proposed project should determine the project duration. The maximum duration
shall not exceed 12 months.
Timelines
Quarterly submission dates will be posted here. GA will review proposals on a quarterly basis for
a duration of 24 months. Applicants are allowed to revise and resubmit their proposal at each
quarterly submission date. Quarterly submission dates will occur in January, March, June, and
September of each year. The next submission date will be January 17, 2025. Please check the
GA website for the exact deadlines for each subsequent submission.
Evaluation Criteria
Applicants are advised to read and understand GA’s Strategic Plan. All program objectives must
align with GA’s goals and demonstrate a clear understanding of GA’s mission and specific purpose
of this RFP.
The following criteria will be used to evaluate submissions:
• Significance of the need/problem and potential to increase knowledge or public health
practice
• Program approach with rationale for program design, specific issue, priority
population, intervention content, and procedures
• Preliminary evidence and/or theory to justify the approach
• Feasibility of the program plan, list of project deliverables, and timelines
• Clearly defined objectives with basic evaluation measures for process or outcome
evaluation and indicators that align with core elements of the program
• The expertise and prior experience of the Principal Investigator and named staff,
including demonstrated experience on similar programs
• The research environment including description of adequate physical, financial, and
intellectual resources to meet the aims of the proposed program
• The communication and dissemination plan for results, as appropriate to the scope of
the program
• Budget relative to the program’s significance and contribution
• Key organizational documents provided to GA as part of the due diligence process, as
outlined in Grant Solicitation and Application Process
Each application will undergo a scientific review by GA in accordance with the following
scoring criteria (see Table 1; also see GA’s website):
____________________________________________________________________________________________________
___ Cessation Education: Advancing Innovative Smoking Cessation through Dissemination, Implementation, and Training
Grants
Quarterly Funding Announcement Small-Scale Page 8 of 12

Table 1 Evaluation and Scoring Criteria
Criterion 1 2 3 4
Description Importance of the Project Factors Expertise and Assessed but
Project Resources not scored
Weight 25% 50% 25% n/a
a) Significance a) Implementation a) Qualifications of a) Budget
Approach Project Leads and
Named Staff
b) Actionability b) Feasibility b) Organizational b) Communication
Scoring Resources and and Dissemination
Elements Project Plan (if relevant)
Environment
c) Alignment with
GA research
priorities
The applicant organization/institute must have the appropriate infrastructure in place to comply
with reporting and other grant agreement requirements. The GA Grants Management team is the
primary reviewer of the detailed budget and all grant agreement requirements. While the scientific
review panel does not assign a score to the budget, they review the budget in the context of the
proposed program and consider overall costs as a factor in their recommendations (“budget relative
to significance and scientific contribution”).
Submission Instructions
Applications should be submitted through GA’s online portal, which can be accessed here. This
link will start a new application form. Upon clicking the link, you will be prompted to log in, and
then be taken to the application form.
The application form has links to three templates, which are also listed here:
• Proposal template
• Budget template
• Work plan template
You may save your application at any time by using the Save & Finish Later button at the end of
each page. To return to an in-progress application, log in to the portal. A list of application portal
FAQs can be found here.
If you have any technical issues during the application process, please contact the Grants
Management Team via support@actiontoendsmoking.org and we will be happy to help.
_______________________________________________________________________________________________________
Cessation Education: Advancing Innovative Smoking Cessation through Dissemination, Implementation, and Training Grants
Quarterly Funding Announcement Small-Scale Page 9 of 12

Key Information
Global Action makes no representations that any grant proposal will be funded. All decisions to
fund grants remain in the sole discretion of Global Action. Grant proposals and related
documentation will be disclosed to employees, consultants, legal counsel, and others. Grant
proposals and related documentation will not be treated as confidential and Global Action does
not maintain the confidentiality of any such materials. Grant applicants should carefully consider
the content of grant proposals and related documentation and not include any proprietary or
confidential information if there is any concern about the impact of disclosure of these materials.
To be considered for an award, the applicant agrees that GA may:
• amend or cancel the RFP, in whole or in part, at any time;
• extend the deadline for submitting responses;
• determine whether a response does or does not substantially comply with the
requirements of the RFP;
• issue multiple awards.
The applicant must ensure that it has responded to the RFP with complete honesty and accuracy. If
information in the applicant’s response changes after submission of an application, the applicant
will supplement its response in writing with any deletions, additions, or changes within five days
of the change. Any material misrepresentation, including omissions, may disqualify the applicant
from consideration for an award.
Grants that Global Action Does Not Fund
Grants that Global Action does not fund include those that are prohibited by applicable laws and
regulations including grants in support of lobbying or political campaign activities. These include
grants relating to attempts to influence legislation, either by communicating with government
personnel who are involved in the legislative process or urging the public to do so. These
prohibited grants include both domestic and international activities. Similarly, Global Action grant
monies are not used to influence the outcome of any political campaigns or to conduct voter
registration drives, neither within the United States or abroad. Global Action generally may fund
grant activity that properly qualifies as an exception to lobbying, such as grants for nonpartisan
analysis, study, or research, and grant work being performed in response to a written request for
technical assistance.
In addition, grants will not be made to any organization that is not authorized in its country of
origin to receive grant funds from Global Action and/or whom Global Action is prohibited or
restricted by law or regulation from funding. Global Action’s rigorous procedures for making and
monitoring grants ensure that its grant funds are used for the intended charitable purposes and not
to support terrorist or other illegal activities.
_______________________________________________________________________________________________________
Cessation Education: Advancing Innovative Smoking Cessation through Dissemination, Implementation, and Training Grants
Quarterly Funding Announcement Small-Scale Page 10 of 12

About Global Action to End Smoking
Global Action to End Smoking is an independent, U.S. nonprofit 501(c)(3) grantmaking
organization whose mission is to end the smoking epidemic. It is dedicated to accelerating science-
based efforts worldwide to end combustible tobacco use, which remains the leading preventable
cause of death globally. Global Action focuses on three main subject areas: Health and Science
Research, Cessation Education, and Agricultural Transformation. Historically, Global Action
received funding through PMI Global Services. As of September 2023, the funding agreement was
terminated, and Global Action formally adopted a policy not to seek or accept funding from
companies that produce tobacco or non-medicinal nicotine products.
References
1. World Health Organization WHO (2023). Fact Sheet Tobacco [Internet]. 31 July 2023 [about 6 screens].
Available from: https://www.who.int/news-room/fact-sheets/detail/tobacco
[accessed 17 July 2024]
2. GBD 2019 Tobacco Collaborators (2021). Spatial, temporal, and demographic patterns in prevalence of
smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic
analysis from the Global Burden of Disease Study 2019. Lancet (London, England), 397(10292), 2337–2360.
https://doi.org/10.1016/S0140-6736(21)01169-7
3. Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services (2024).
Public Health Strategies for Tobacco Prevention and Control.
https://www.cdc.gov/reach/php/strategies/tobacco-prevention-
control.html#:~:text=Those%20groups%20include%20young%20people%2C%20people%20who%20live,
American%20Indian%20and%20Alaska%20Native%2C%20Asian%2C%20or%20LGBTQ%2B. [accessed
25 September 2024].
4. WHO clinical treatment guideline for tobacco cessation in adults. Retrieved from
https://iris.who.int/bitstream/handle/10665/377825/9789240096431-eng.pdf?sequence=4 [accessed 9
August 2024].
5. Ahluwalia IB, Tripp AL, Dean AK, Mbulo L, Arrazola RA, Twentyman E, King BA. Tobacco Smoking
Cessation and Quitline Use Among Adults Aged ≥15 Years in 31 Countries: Findings From the Global Adult
Tobacco Survey. Am J Prev Med. 2021 Mar;60(3 Suppl 2):S128-S135. doi: 10.1016/j.amepre.2020.04.029.
PMID: 33663700; PMCID: PMC9020833.
6. Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services (2024).
Smoking Cessation: Fast Facts. https://www.cdc.gov/tobacco/php/data-statistics/smoking-
cessation/index.html. [accessed 25 September 2024].
7. Gottlieb, S., & Zeller, M. (2017). A Nicotine-Focused Framework for Public Health. The New England
journal of medicine, 377(12), 1111–1114. https://doi.org/10.1056/NEJMp1707409
8. Lindson N, Butler AR, McRobbie H, Bullen C, Hajek P, Begh R, Theodoulou A, Notley C, Rigotti NA,
Turner T, Livingstone-Banks J, Morris T, Hartmann-Boyce J. Electronic cigarettes for smoking cessation.
Cochrane Database of Systematic Reviews 2024, Issue 1. Art. No.: CD010216. DOI:
10.1002/14651858.CD010216.pub8. [accessed 16 July 2024].
_______________________________________________________________________________________________________
Cessation Education: Advancing Innovative Smoking Cessation through Dissemination, Implementation, and Training Grants
Quarterly Funding Announcement Small-Scale Page 11 of 12

9. Royal College of Physicians (2016). Nicotine without smoke: tobacco harm reduction.
https://www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction [accessed
31 July 2024]
10. Villanti, A. C., Peasley-Miklus, C., Mercincavage, M., Mays, D., Donny, E. C., Cappella, J. N., & Strasser,
A. A. (2023). Effect of nicotine corrective messaging on nicotine-related beliefs in US adults: a randomised
controlled trial. Tobacco control, tc-2023-058252. Advance online publication. https://doi.org/10.1136/tc-
2023-058252
11. Global Action to End Smoking (2022). “2022 Doctors’ Survey” Retrieved from
https://globalactiontoendsmoking.org/wp-content/uploads/2024/02/Global-Final-SERMO-Doctors-Survey-
7-5-2023.pdf [accessed 25 July 2024]
12. McNeill A, Brose LS, Calder R, Bauld L & Robson D (2018). Evidence review of ecigarettes and heated
tobacco products 2018. A report commissioned by Public Health England. London: Public Health England.
Available from:
https://assets.publishing.service.gov.uk/media/5a981c6740f0b67aa27253cc/Evidence_review_of_e-
cigarettes_and_heated_tobacco_products_2018.pdf [accessed 8 August 2024]
13. Food and Drug Administration (2024). Nicotine Is Why Tobacco Products Are Addictive. Available from:
https://www.fda.gov/tobacco-products/health-effects-tobacco-use/nicotine-why-tobacco-products-are-
addictive [accessed 8 August 2024]
_______________________________________________________________________________________________________
Cessation Education: Advancing Innovative Smoking Cessation through Dissemination, Implementation, and Training Grants
Quarterly Funding Announcement Small-Scale Page 12 of 12